Mr Brown has 35 years experience in the healthcare industry, in medical devices (including in vitro diagnostic medical devices) and personalised medicine. Prior to joining CurveBeam, Mr Brown held marketing roles at Baxter Diagnostics (Australia and United Kingdom), Roche Molecular Systems Inc. (Switzerland and U.S.) and Digene Corporation (U.S. and Germany) and was Chief Executive Officer at ImpediMed Limited (ASX:IPD). Until April 2023, Mr Brown was a director of Australian biotechnology company Immunexpress Pty Ltd. He is also a director of an Australian management consulting company, Cintra Consulting Pty Ltd. He has previously served as a director of Trinity Biotech plc (Nasdaq: TRIB), ImpediMed Limited (ASX:IPD), Minomic International Limited and the University of Queenslands commercialisation company, UniQuest Pty Ltd.
